Davis R M Inc. Has $90.65 Million Holdings in Danaher Co. (NYSE:DHR)

Davis R M Inc. trimmed its position in shares of Danaher Co. (NYSE:DHR) by 1.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 326,049 shares of the conglomerate’s stock after selling 3,833 shares during the quarter. Danaher makes up 1.8% of Davis R M Inc.’s holdings, making the stock its 13th biggest holding. Davis R M Inc.’s holdings in Danaher were worth $90,648,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in the company. Bank of Hawaii boosted its stake in shares of Danaher by 23.8% during the third quarter. Bank of Hawaii now owns 14,348 shares of the conglomerate’s stock valued at $3,989,000 after purchasing an additional 2,763 shares in the last quarter. Douglass Winthrop Advisors LLC boosted its stake in shares of Danaher by 3.1% during the third quarter. Douglass Winthrop Advisors LLC now owns 76,095 shares of the conglomerate’s stock valued at $21,156,000 after purchasing an additional 2,256 shares in the last quarter. Fisher Asset Management LLC boosted its stake in shares of Danaher by 2.6% during the third quarter. Fisher Asset Management LLC now owns 4,552,640 shares of the conglomerate’s stock valued at $1,265,725,000 after purchasing an additional 116,299 shares in the last quarter. Daiwa Securities Group Inc. boosted its stake in shares of Danaher by 2.1% during the third quarter. Daiwa Securities Group Inc. now owns 98,024 shares of the conglomerate’s stock valued at $27,253,000 after purchasing an additional 2,052 shares in the last quarter. Finally, Hartford Funds Management Co LLC boosted its stake in shares of Danaher by 4.5% during the third quarter. Hartford Funds Management Co LLC now owns 1,794 shares of the conglomerate’s stock valued at $499,000 after purchasing an additional 77 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Up 0.3 %

Shares of NYSE:DHR opened at $235.84 on Monday. The stock has a fifty day simple moving average of $258.15 and a two-hundred day simple moving average of $260.03. The stock has a market capitalization of $170.34 billion, a price-to-earnings ratio of 45.01, a PEG ratio of 4.34 and a beta of 0.85. Danaher Co. has a 12-month low of $215.68 and a 12-month high of $281.70. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. During the same quarter in the previous year, the business earned $2.02 earnings per share. The company’s revenue was up 3.1% on a year-over-year basis. On average, research analysts anticipate that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.46%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s dividend payout ratio (DPR) is 20.61%.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the company. Raymond James lowered their price objective on Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a research report on Wednesday, October 23rd. Royal Bank of Canada lowered their target price on Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. Wells Fargo & Company assumed coverage on Danaher in a report on Tuesday, August 27th. They set an “equal weight” rating and a $280.00 price objective for the company. Stephens restated an “overweight” rating and set a $315.00 price objective on shares of Danaher in a report on Wednesday, October 23rd. Finally, Evercore ISI boosted their price objective on Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. Six investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $287.16.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.